Page 2 - Crown Bioscience News Today

/PRNewswire/ -- The "Animal Model Market Size, Share & Trends Analysis Report By Animal Type (Mice, Guinea Pigs), By Application (Cancer, Infectious Disease),...

HAMBURG, Germany--(BUSINESS WIRE)--Sep 11, 2023--

/PRNewswire/ -- The Patient-Derived Xenograft (PDX) model industry is poised for remarkable growth in the near future, revolutionizing the landscape of...

Crown Bioscience a global contract research organization CRO and JSR Life Sciences company has announced that its collaborative work with HanX Biopharmaceutical Co. Ltd. HanX employing a unique and broad portfolio of preclinical modeling in support of HanXs successful FDA Investigational New Drug IND application has been published in Scientific Reports a journal within the Nature portfolio.

"Clinical Contract Research Services Industry Research Study", the recent report by Orbisresearch.com offers insightful information on a number of mar

JSR Corporation Summary of Q&A session of media/analysts/institutional investors call regarding Overview of Opinion and Recommendation on Scheduled Commencement...

/PRNewswire/ -- In the near future, the high-throughput screening (HTS) industry is poised to undergo significant advancements, revolutionizing the field of...

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma

/PRNewswire/ -- The "Global Diagnostics Partnering Terms and Agreements 2016-2023" report has been added to ResearchAndMarkets.coms offering. The Global...

Datalys Datalys provides the Oncology Based In-vitro CRO size information and market trends along with factors and parameters impacting it in both sho